FIELD: chemistry.
SUBSTANCE: present invention relates to a method of preparing a composition containing one or more compounds of formula I (I), where R1, R2 and R3 are each independently H or -NO, where n is 0 or 1; where when n is 0, R1 is H; and also where, when n is 1, R2 is H provided that at least one of R1, R2 and R3 is -NO. This method involves a step of reacting a corresponding compound of formula I, where R1, R2 and R3 are H with a nitrite source, optionally in the presence of a suitable acid. When the nitrite source is organic nitrite, step (i) is carried out in a suitable organic solvent; and when the nitrite source is inorganic nitrite, step (i) is carried out in a two-phase mixture of solvents containing an aqueous phase and a non-aqueous phase. Method further includes a step of adding an additional amount of the compound of Formula I, where R1, R2 and R3 are H, and compositions of one or more compounds of Formula I and a compound of Formula I, where R1, R2 and R3 are H, contains from 0.01% to 9 wt.% of one or more compounds of Formula I. Invention also relates to a composition for treating a pathological condition in which the introduction of NO is characterized by a positive effect, to a pharmaceutical composition, a combination product, a pharmaceutical formulation and a set of elements containing said composition, to a method of producing a combined product, to applications of the disclosed products, as well as to a method of treating a pathological condition in which the introduction of NO is characterized by a positive effect.
EFFECT: development of a method providing a relatively high concentration of compounds in a solution, minimizing the risk of sudden and spontaneous decomposition and reducing the likelihood of side effects when the product obtained by implementing said method is used for treatment.
38 cl, 3 dwg, 1 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
QUINAZOLINONE DERIVATIVES EFFECTIVE AS VANILLOID ANTAGONISTS | 2005 |
|
RU2449995C2 |
DERIVATIVES OF 3,4-BIS-(FURAZAN-3-YL)FUROXANE PRODUCING NITROGEN OXIDE, ACTIVATING GUANYLATE CYCLASE SOLUBLE FORM, INHIBITING PLATELET AGGREGATION AND ELICITING SPASMOLYTIC, VASODILATING, HYPOTENSIVE EFFECT AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2240321C2 |
INCLUSION COMPLEXES OF DERIVATIVES OF 1,2,5-OXA- -DIAZOLE-2-OXIDE WITH POLYCYCLIC DERIVATIVES OF GLUCOPYRANOSE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2186782C1 |
QUINAZOLINE DERIVATIVES EFFECTIVE AS VANILOID ANTAGONISTS | 2005 |
|
RU2396261C2 |
1,2,5-OXADIAZOLO[3,4-D]PYRIDAZINE-5,6-DIOXIDE DERIVATIVES AS ACTIVATORS OF SOLUBLE FORM OF GUANYLATE-CYCLASE AND AGENTS ACTIVE IN TREATMENT OF CENTRAL NERVOUS SYSTEM, AND COMPOSITIONS BASED ON THESE COMPOUNDS | 1997 |
|
RU2165256C2 |
INHIBITORS OF NO-SYNTHASE BASED ON MERCAPTO- AND SELENODERIVATIVES | 1996 |
|
RU2191575C2 |
CHROMENONE ANALOGUES AS SIRTUIN MODULATORS | 2009 |
|
RU2527269C2 |
NAPHTHALENE DERIVATIVES | 2001 |
|
RU2354646C2 |
CONJUGATES AND PROSTAGLANDIN DERIVATIVES FOR TREATING GLAUCOMA AND INTRAOCULAR HYPERTENSION | 2015 |
|
RU2712221C2 |
QUINAZOLINONE, QUINOLONE AND RELATED ANALOGUES AS SIRTUIN MODULATORS | 2009 |
|
RU2519779C2 |
Authors
Dates
2024-11-22—Published
2019-11-27—Filed